We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$890M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
United Parcel Service
UPS
$88.5B
| $29.6M | 0.07% |
170,180
-64,252
| -27% | -$11.1M |
|
352
Target
TGT
$69.6B
| $29.4M | 0.07% |
198,099
-306,166
| -61% | -$48M |
|
353
Prologis
PLD
$132B
| $29.4M | 0.07% |
260,566
-24,845
| -9% | -$2.75M |
|
354
Amphenol
APH
$210B
| $29.2M | 0.07% |
772,062
+108,582
| +16% | +$4.11M |
|
355
Enovis
ENOV
$1.45B
| $29.1M | 0.07% |
544,450
+125,312
| +30% | +$6.47M |
|
356
US Bancorp
USB
$100B
| $29.1M | 0.07% |
667,890
+405,071
| +154% | +$17.3M |
|
357
Intuit
INTU
$91.9B
| $29M | 0.07% |
75,200
-41,300
| -35% | -$16.4M |
|
358
EQT Corp
EQT
$33.9B
| $28.9M | 0.07% |
856,278
+617,102
| +258% | +$24.8M |
|
359
Carrier Global
CARR
$52.5B
| $28.9M | 0.07% |
700,714
+110,645
| +19% | +$4.49M |
|
360
Synaptics
SYNA
$4.16B
| $28.9M | 0.07% |
310,091
+224,380
| +262% | +$21.6M |
|
361
GE Aerospace
GE
$381B
| $28.8M | 0.07% |
554,855
-434,511
| -44% | -$21.4M |
|
|
SCHW
362
Charles Schwab
SCHW
$187B
| $28.8M | 0.07% |
347,568
-64,633
| -16% | -$5.02M |
|
363
Evercore
EVR
$11.6B
| $28.7M | 0.07% |
264,317
-99,479
| -27% | -$10.4M |
|
364
W.R. Berkley
WRB
$26.2B
| $28.5M | 0.06% |
588,087
+65,472
| +13% | +$3.16M |
|
365
Sotera Health
SHC
$5.43B
| $28.3M | 0.06% |
3,477,868
+2,785,022
| +402% | +$20.8M |
|
366
Gentex
GNTX
$5.07B
| $28.3M | 0.06% |
1,038,958
-266,850
| -20% | -$7.12M |
|
|
PACW
367
DELISTED
PacWest Bancorp
PACW
| $28.3M | 0.06% |
1,236,882
-99,211
| -7% | -$2.41M |
|
368
Public Service Enterprise Group
PEG
$37.3B
| $28.1M | 0.06% |
458,356
-23,840
| -5% | -$1.38M |
|
369
Dropbox
DBX
$7.52B
| $28M | 0.06% |
1,264,060
+205,306
| +19% | +$4.52M |
|
370
Corning
GLW
$137B
| $27.9M | 0.06% |
877,945
+150,809
| +21% | +$4.89M |
|
371
Copa Holdings
CPA
$5.55B
| $27.8M | 0.06% |
336,173
-3,634
| -1% | -$286K |
|
372
nVent Electric
NVT
$27B
| $27.8M | 0.06% |
732,343
-128,860
| -15% | -$4.76M |
|
373
Loews
L
$23.2B
| $27.7M | 0.06% |
474,562
+105,463
| +29% | +$5.88M |
|
374
Virtu Financial
VIRT
$4.95B
| $27.7M | 0.06% |
1,354,938
+22,999
| +2% | +$499K |
|
375
Associated Banc-Corp
ASB
$5.98B
| $27.5M | 0.06% |
1,192,418
-347,056
| -23% | -$8.01M |
|
Similar funds
VGA
AQR Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
- AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
- AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.